This vaccine reduces risk of melanoma coming back. Can it work for other cancers?
Researchers are exploring whether a vaccine that shows promise in preventing melanoma recurrence can be adapted to treat other types of cancer. Studies by Moderna and Merck are among several global efforts underway, suggesting a potential shift in cancer therapy in the next decade.
AI-generated summary
Read this story on The Seattle Times